Bildkälla: Stockfoto

Xspray Pharma: Support from principal owners - Redeye

Redeye considers the declaration of intents for the TO6 warrants from Xspray's largest shareholders to be very supportive news, especially considering that the company stands before a PDUFA date and potential US approval for Dasynoc at the end of July.

Redeye considers the declaration of intents for the TO6 warrants from Xspray's largest shareholders to be very supportive news, especially considering that the company stands before a PDUFA date and potential US approval for Dasynoc at the end of July.
Börsvärldens nyhetsbrev
ANNONSER